Ambrx Biopharma Cayman, Inc. Quarterly Other Assets, Current in USD from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of current assets classified as other.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Other Assets, Current history and growth rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Other Assets, Current for the quarter ending June 30, 2023 was $981K, a 0.51% decline year-over-year.

Other Assets, Current, Quarterly (USD)

Other Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$981K	-$5K	-0.51%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$238K			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$487K	+$257K	+112%	Dec 31, 2022	10-Q	2023-08-09
Q2 2022	$986K			Jun 30, 2022	6-K	2022-08-29
Q4 2021	$230K	+$39K	+20.4%	Dec 31, 2021	10-K	2023-03-30
Q4 2020	$191K			Dec 31, 2020	20-F	2022-04-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.